We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Highly Elastic Protein Gel Encourages Wound Healing

By LabMedica International staff writers
Posted on 15 Jul 2015
A new study describes a protein-based gel that mimics many of the properties of elastic tissue—such as skin and blood vessels—when exposed to light.

Researchers at Brigham and Women's Hospital (Boston, MA, USA) and King Abdulaziz University (KAU; Jeddah, Saudi Arabia) successfully developed a photo-crosslinked elastin-like polypeptide (ELP) that contained only canonical amino acids and thiols from a pair of cysteine residues. More...
The thiols embedded into the ELP sequence caused formation of disulfide bonds when exposed to UV light. This allowed the researchers to create a highly elastic hydrogel with mechanical and swelling behavior properties that can be tuned by controlling ELP concentrations.

They then examined the biocompatibility of the engineered ELP hydrogels in vitro, as well as in vivo with subcutaneous implantation in rats. The ELP constructs demonstrated long-term structural stability in vivo and early and progressive host integration without immune response, suggesting their potential for supporting wound repair and as an in vivo hemostatic material for treating bleeding wounds. The researchers also found that combining the hydrogel with silica nanoparticles formed an even more powerful barrier. The study was published in the July 2015 issue of Advanced Functional Materials.

“Our hydrogel has many applications: it could be used as a scaffold to grow cells, or it can be incorporated with cells in a dish and then injected to stimulate tissue growth,” said co-senior author Nasim Annabi, PhD, of the Brigham biomedical engineering division. “In addition, the material can be used as a sealant, sticking to the tissue at the site of injury and creating a barrier over a wound. We see great potential for use in the clinic. Our method is simple, the material is biocompatible, and we hope to see it solve clinical problems in the future.”

“Hydrogels, jelly-like materials that can mimic the properties of human tissue, are widely used in biomedicine, but currently available materials have limitations,” added co-senior author Ali Khademhosseini, PhD, of Brigham and KAU.” Some synthetic gels degrade into toxic chemicals over time, and some natural gels are not strong enough to withstand the flow of arterial blood through them.”

Related Links:

Brigham and Women's Hospital
King Abdulaziz University



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.